Stock Events

Stock Events

Stoke Therapeutics (STOK) Q2 2024 Earnings

6MayConfirmed

Q1 2023

Q2 2023

Q3 2023

Q2 2024

-0.69

-0.64

-0.58

-0.53

Details

Expected EPS

-0.609914

Actual EPS

-0.57

Surprise EPS

0.04

Surprise Percent

+6.54%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.57 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.